ArticleEuropean heart journal. Case reports2026
Suspected native aortic valve thrombosis complicated by recurrent left main coronary artery embolism and acquired Gerbode defect: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Native aortic valve thrombosis (NAVT) is an uncommon cause of coronary embolism and myocardial infarction. In patients with severe aortic valve disease treated surgically, a post-operative communication between the left ventricle and right atrium (i.e. acquired Gerbode defect) is a rare complication. Case summary: We report the case of a 67-year-old man with suspected NAVT presenting with myocardial infarction and a post-operative acquired Gerbode defect. Coronary angiography showed a floating thrombus in the left main coronary artery without significant culprit-vessel atherosclerotic disease, suggesting coronary embolism. Multiple aspiration thrombectomies and glycoprotein IIb/IIIa inhibitor therapy were performed. Recurrent chest pain prompted repeat coronary angiography, which confirmed thrombus recurrence and resolution after repeat treatment. Intravascular ultrasound excluded significant culprit-vessel atherosclerotic disease. Aspirated material revealed a subacute thrombus with microcalcifications on histopathological examination. Echocardiography showed severe calcific aortic stenosis, a likely predisposing factor for NAVT. Atrial fibrillation had not been documented during the embolic event or previously and was only detected later during hospitalization, prompting initiation of anticoagulation (CHA2DS2-VASc score 3). Consequently, dual antiplatelet therapy was replaced with apixaban and ticagrelor until surgery. After clinical stabilization, the patient underwent surgical aortic valve replacement. No left atrial appendage thrombus was found intra-operatively after 3 months of anticoagulation. Post-operatively, multimodal imaging identified and quantified an acquired Gerbode defect. Given its haemodynamic insignificance, a conservative approach was adopted. Discussion: This case highlights underreported complications of severe aortic stenosis and its treatment, emphasizing the importance of multimodal imaging in the diagnosis of NAVT and post-operative Gerbode defect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.